Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peritoneal Neoplasms | 9 | 2025 | 42 | 5.870 |
Why?
|
Colorectal Neoplasms | 12 | 2025 | 576 | 4.210 |
Why?
|
Appendiceal Neoplasms | 6 | 2025 | 18 | 3.840 |
Why?
|
Cytoreduction Surgical Procedures | 9 | 2025 | 43 | 3.440 |
Why?
|
Hyperthermia, Induced | 5 | 2023 | 54 | 2.810 |
Why?
|
Adenocarcinoma | 9 | 2025 | 1023 | 2.560 |
Why?
|
Circulating Tumor DNA | 2 | 2025 | 35 | 1.730 |
Why?
|
Microbiota | 3 | 2023 | 384 | 1.700 |
Why?
|
Gastrointestinal Microbiome | 5 | 2024 | 698 | 1.620 |
Why?
|
Carcinoma, Pancreatic Ductal | 4 | 2021 | 153 | 1.440 |
Why?
|
Rectal Neoplasms | 4 | 2025 | 78 | 1.250 |
Why?
|
Biomarkers, Tumor | 7 | 2025 | 1534 | 1.170 |
Why?
|
Pancreatic Neoplasms | 4 | 2021 | 690 | 1.080 |
Why?
|
Combined Modality Therapy | 8 | 2025 | 1237 | 1.050 |
Why?
|
Melanoma | 5 | 2022 | 943 | 1.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 5 | 2025 | 193 | 0.900 |
Why?
|
Survival Rate | 11 | 2025 | 2051 | 0.890 |
Why?
|
Pseudomyxoma Peritonei | 1 | 2023 | 2 | 0.850 |
Why?
|
Hepatectomy | 1 | 2024 | 112 | 0.840 |
Why?
|
B7-H1 Antigen | 2 | 2020 | 120 | 0.810 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2022 | 81 | 0.740 |
Why?
|
Neoplasm Metastasis | 1 | 2024 | 704 | 0.730 |
Why?
|
Laparoscopy | 4 | 2025 | 490 | 0.720 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 79 | 0.710 |
Why?
|
Humans | 60 | 2025 | 125025 | 0.680 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2021 | 74 | 0.680 |
Why?
|
Appendicitis | 1 | 2021 | 128 | 0.660 |
Why?
|
Neutropenia | 1 | 2021 | 196 | 0.660 |
Why?
|
Mesothelioma | 1 | 2020 | 88 | 0.640 |
Why?
|
Prognosis | 10 | 2025 | 4683 | 0.620 |
Why?
|
Stomach Neoplasms | 2 | 2024 | 547 | 0.600 |
Why?
|
Neoplasm Proteins | 2 | 2020 | 680 | 0.590 |
Why?
|
Biguanides | 1 | 2017 | 13 | 0.570 |
Why?
|
Lactams | 1 | 2017 | 19 | 0.570 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2025 | 157 | 0.570 |
Why?
|
Digoxin | 1 | 2017 | 43 | 0.560 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 2093 | 0.540 |
Why?
|
Retrospective Studies | 17 | 2025 | 16334 | 0.530 |
Why?
|
Karyopherins | 1 | 2016 | 36 | 0.520 |
Why?
|
Longevity | 1 | 2017 | 135 | 0.520 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2016 | 118 | 0.520 |
Why?
|
Caenorhabditis elegans | 1 | 2017 | 227 | 0.510 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 177 | 0.500 |
Why?
|
Neoplasms | 6 | 2024 | 2790 | 0.480 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 4 | 2022 | 91 | 0.480 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2023 | 1245 | 0.470 |
Why?
|
Enzyme Inhibitors | 1 | 2017 | 587 | 0.460 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2020 | 376 | 0.460 |
Why?
|
Autophagy | 1 | 2017 | 395 | 0.450 |
Why?
|
Cell Survival | 4 | 2021 | 819 | 0.450 |
Why?
|
Metabolic Syndrome | 1 | 2017 | 342 | 0.440 |
Why?
|
Liver Neoplasms | 1 | 2024 | 1316 | 0.440 |
Why?
|
Cell Nucleus | 1 | 2016 | 664 | 0.440 |
Why?
|
Middle Aged | 19 | 2025 | 26670 | 0.420 |
Why?
|
Adenocarcinoma, Mucinous | 2 | 2023 | 37 | 0.420 |
Why?
|
Neoadjuvant Therapy | 3 | 2025 | 344 | 0.420 |
Why?
|
Carcinogenesis | 3 | 2022 | 340 | 0.400 |
Why?
|
Lung Neoplasms | 3 | 2020 | 1653 | 0.390 |
Why?
|
Mutation | 6 | 2025 | 5897 | 0.380 |
Why?
|
MAP Kinase Signaling System | 4 | 2017 | 313 | 0.380 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2025 | 743 | 0.380 |
Why?
|
Aged | 18 | 2025 | 19653 | 0.380 |
Why?
|
Signal Transduction | 7 | 2023 | 4595 | 0.360 |
Why?
|
Mice | 14 | 2023 | 17711 | 0.340 |
Why?
|
Carrier Proteins | 2 | 2006 | 1027 | 0.330 |
Why?
|
ral GTP-Binding Proteins | 2 | 2021 | 4 | 0.310 |
Why?
|
Robotic Surgical Procedures | 2 | 2025 | 206 | 0.310 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2020 | 348 | 0.310 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2011 | 493 | 0.290 |
Why?
|
Immunity, Innate | 2 | 2011 | 372 | 0.290 |
Why?
|
Female | 25 | 2025 | 66669 | 0.290 |
Why?
|
Lymph Node Excision | 2 | 2024 | 165 | 0.290 |
Why?
|
Lymphatic Metastasis | 3 | 2025 | 417 | 0.280 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2016 | 561 | 0.270 |
Why?
|
Animals | 16 | 2023 | 34205 | 0.270 |
Why?
|
Male | 21 | 2025 | 61429 | 0.260 |
Why?
|
Mitogen-Activated Protein Kinases | 3 | 2004 | 208 | 0.260 |
Why?
|
Ubiquitin | 2 | 2004 | 142 | 0.260 |
Why?
|
Fecal Microbiota Transplantation | 2 | 2024 | 97 | 0.260 |
Why?
|
Microsatellite Instability | 2 | 2025 | 38 | 0.250 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2020 | 914 | 0.250 |
Why?
|
Adult | 12 | 2025 | 29452 | 0.250 |
Why?
|
Androgen Receptor Antagonists | 2 | 2023 | 36 | 0.240 |
Why?
|
Lysosomes | 2 | 2017 | 239 | 0.240 |
Why?
|
Liquid Biopsy | 1 | 2025 | 14 | 0.240 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2025 | 1155 | 0.240 |
Why?
|
Synthetic Lethal Mutations | 1 | 2024 | 10 | 0.230 |
Why?
|
HeLa Cells | 3 | 2017 | 788 | 0.230 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2025 | 359 | 0.230 |
Why?
|
SUMO-1 Protein | 1 | 2004 | 8 | 0.220 |
Why?
|
Follow-Up Studies | 7 | 2025 | 5167 | 0.220 |
Why?
|
Nerve Growth Factor | 1 | 2004 | 21 | 0.220 |
Why?
|
Minimally Invasive Surgical Procedures | 2 | 2025 | 190 | 0.220 |
Why?
|
Xenopus Proteins | 1 | 2004 | 60 | 0.220 |
Why?
|
RNA, Small Interfering | 3 | 2016 | 670 | 0.220 |
Why?
|
RNA Interference | 3 | 2016 | 507 | 0.210 |
Why?
|
Antineoplastic Agents | 3 | 2023 | 1714 | 0.210 |
Why?
|
ras Proteins | 1 | 2004 | 137 | 0.200 |
Why?
|
Operating Rooms | 1 | 2023 | 68 | 0.200 |
Why?
|
Dysbiosis | 1 | 2024 | 122 | 0.200 |
Why?
|
Receptors, Androgen | 2 | 2023 | 414 | 0.200 |
Why?
|
Immunotherapy | 3 | 2022 | 677 | 0.200 |
Why?
|
Surgical Stapling | 1 | 2022 | 18 | 0.200 |
Why?
|
Neoplasms, Second Primary | 1 | 2024 | 146 | 0.190 |
Why?
|
Lymph Nodes | 1 | 2024 | 378 | 0.190 |
Why?
|
Aged, 80 and over | 6 | 2025 | 6535 | 0.190 |
Why?
|
Prostatic Neoplasms, Castration-Resistant | 1 | 2023 | 88 | 0.190 |
Why?
|
Peritoneum | 1 | 2022 | 37 | 0.190 |
Why?
|
Immune System | 1 | 2022 | 90 | 0.190 |
Why?
|
Molecular Targeted Therapy | 2 | 2022 | 376 | 0.190 |
Why?
|
Anastomosis, Surgical | 1 | 2022 | 165 | 0.190 |
Why?
|
Dietary Fiber | 1 | 2021 | 75 | 0.190 |
Why?
|
CTLA-4 Antigen | 1 | 2021 | 61 | 0.180 |
Why?
|
Platinum Compounds | 1 | 2020 | 6 | 0.180 |
Why?
|
Pemetrexed | 1 | 2020 | 9 | 0.180 |
Why?
|
Suture Techniques | 1 | 2022 | 193 | 0.180 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2021 | 44 | 0.180 |
Why?
|
Perfusion | 1 | 2022 | 206 | 0.180 |
Why?
|
Cell Line, Tumor | 6 | 2021 | 3422 | 0.170 |
Why?
|
Portal Vein | 1 | 2021 | 91 | 0.170 |
Why?
|
Enzyme Activation | 4 | 2006 | 623 | 0.170 |
Why?
|
Bacteria | 1 | 2024 | 476 | 0.170 |
Why?
|
Thrombospondin 1 | 1 | 2020 | 23 | 0.170 |
Why?
|
Emergencies | 1 | 2021 | 172 | 0.170 |
Why?
|
Programmed Cell Death 1 Receptor | 1 | 2021 | 128 | 0.170 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2020 | 54 | 0.170 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2020 | 48 | 0.170 |
Why?
|
Viruses | 1 | 2021 | 121 | 0.170 |
Why?
|
Oncogenes | 1 | 2020 | 176 | 0.160 |
Why?
|
Biopsy | 1 | 2023 | 1242 | 0.160 |
Why?
|
Ovarian Neoplasms | 1 | 2023 | 420 | 0.160 |
Why?
|
Membrane Proteins | 2 | 2004 | 1538 | 0.160 |
Why?
|
Immunocompromised Host | 1 | 2021 | 292 | 0.160 |
Why?
|
Gene Expression | 1 | 2004 | 1550 | 0.160 |
Why?
|
Probiotics | 1 | 2021 | 215 | 0.150 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2021 | 436 | 0.150 |
Why?
|
Surgeons | 1 | 2023 | 255 | 0.150 |
Why?
|
Down-Regulation | 1 | 2020 | 692 | 0.150 |
Why?
|
Genomics | 2 | 2020 | 1520 | 0.150 |
Why?
|
Starvation | 1 | 2017 | 15 | 0.140 |
Why?
|
Autophagosomes | 1 | 2017 | 25 | 0.140 |
Why?
|
Nerve Tissue Proteins | 1 | 2004 | 1128 | 0.140 |
Why?
|
Up-Regulation | 1 | 2020 | 874 | 0.140 |
Why?
|
Protein Kinase Inhibitors | 2 | 2022 | 543 | 0.140 |
Why?
|
Caloric Restriction | 1 | 2017 | 83 | 0.140 |
Why?
|
I-kappa B Kinase | 1 | 2017 | 61 | 0.140 |
Why?
|
High-Throughput Screening Assays | 1 | 2017 | 98 | 0.140 |
Why?
|
Follistatin-Related Proteins | 1 | 2016 | 2 | 0.130 |
Why?
|
NF-KappaB Inhibitor alpha | 1 | 2016 | 35 | 0.130 |
Why?
|
Porphyrins | 1 | 2016 | 17 | 0.130 |
Why?
|
Genes, Lethal | 1 | 2016 | 75 | 0.130 |
Why?
|
Cell Differentiation | 1 | 2004 | 1908 | 0.130 |
Why?
|
Pilot Projects | 1 | 2021 | 1395 | 0.130 |
Why?
|
Endosomes | 1 | 2016 | 64 | 0.130 |
Why?
|
Diet, High-Fat | 1 | 2017 | 209 | 0.130 |
Why?
|
Fatty Liver | 1 | 2017 | 190 | 0.130 |
Why?
|
Transfection | 2 | 2011 | 1073 | 0.120 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2016 | 443 | 0.120 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2017 | 734 | 0.120 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2011 | 623 | 0.120 |
Why?
|
Prostatic Neoplasms | 2 | 2023 | 1550 | 0.120 |
Why?
|
Carcinoma, Adenosquamous | 1 | 2015 | 4 | 0.120 |
Why?
|
Gene Regulatory Networks | 2 | 2024 | 365 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2024 | 1984 | 0.120 |
Why?
|
Lipid Metabolism | 1 | 2017 | 356 | 0.120 |
Why?
|
Monocarboxylic Acid Transporters | 1 | 2014 | 31 | 0.120 |
Why?
|
Phosphoproteins | 1 | 2016 | 419 | 0.110 |
Why?
|
HCT116 Cells | 2 | 2011 | 55 | 0.110 |
Why?
|
Glycolysis | 1 | 2014 | 152 | 0.110 |
Why?
|
NF-kappa B | 1 | 2016 | 462 | 0.110 |
Why?
|
Treatment Outcome | 5 | 2025 | 12269 | 0.110 |
Why?
|
Prospective Studies | 2 | 2023 | 6122 | 0.110 |
Why?
|
Cell Proliferation | 2 | 2020 | 2377 | 0.100 |
Why?
|
Nuclear Proteins | 2 | 2016 | 1273 | 0.100 |
Why?
|
Multiprotein Complexes | 2 | 2021 | 210 | 0.100 |
Why?
|
Phosphorylation | 2 | 2021 | 1633 | 0.100 |
Why?
|
Mitochondria | 1 | 2017 | 677 | 0.100 |
Why?
|
Calcium | 1 | 2017 | 1099 | 0.100 |
Why?
|
Muscle Proteins | 1 | 2014 | 414 | 0.090 |
Why?
|
Biomarkers | 1 | 2021 | 3105 | 0.090 |
Why?
|
Digestive System Surgical Procedures | 1 | 2012 | 86 | 0.090 |
Why?
|
von Hippel-Lindau Disease | 1 | 2011 | 20 | 0.090 |
Why?
|
DNA-Binding Proteins | 2 | 2016 | 2055 | 0.090 |
Why?
|
Cryosurgery | 1 | 2011 | 47 | 0.090 |
Why?
|
Intestinal Obstruction | 1 | 2012 | 93 | 0.090 |
Why?
|
Liver | 1 | 2017 | 1747 | 0.090 |
Why?
|
Cell Line | 3 | 2004 | 2717 | 0.080 |
Why?
|
Protein Binding | 3 | 2021 | 1747 | 0.080 |
Why?
|
Exome | 1 | 2015 | 1034 | 0.080 |
Why?
|
Salvage Therapy | 1 | 2011 | 185 | 0.080 |
Why?
|
Apoptosis | 3 | 2020 | 1819 | 0.080 |
Why?
|
Cystectomy | 1 | 2010 | 160 | 0.080 |
Why?
|
Transcription Factors | 2 | 2016 | 2603 | 0.080 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2010 | 188 | 0.080 |
Why?
|
Catheter Ablation | 1 | 2011 | 233 | 0.080 |
Why?
|
Genetic Variation | 1 | 2015 | 1505 | 0.070 |
Why?
|
Endoscopy | 1 | 2010 | 281 | 0.070 |
Why?
|
Palliative Care | 1 | 2012 | 432 | 0.070 |
Why?
|
Neoplasm Invasiveness | 2 | 2025 | 625 | 0.070 |
Why?
|
Rats | 2 | 2004 | 3723 | 0.070 |
Why?
|
Precipitin Tests | 2 | 2004 | 155 | 0.070 |
Why?
|
Kidney Neoplasms | 1 | 2011 | 439 | 0.070 |
Why?
|
Abdominal Injuries | 1 | 2007 | 112 | 0.060 |
Why?
|
Vesicular Transport Proteins | 1 | 2006 | 120 | 0.060 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2010 | 549 | 0.060 |
Why?
|
F-Box-WD Repeat-Containing Protein 7 | 1 | 2025 | 21 | 0.060 |
Why?
|
Protein Kinases | 2 | 2004 | 329 | 0.060 |
Why?
|
Cells, Cultured | 1 | 2011 | 3017 | 0.060 |
Why?
|
Wounds, Nonpenetrating | 1 | 2007 | 211 | 0.060 |
Why?
|
Smad4 Protein | 1 | 2025 | 57 | 0.060 |
Why?
|
Receptor, Notch1 | 1 | 2025 | 66 | 0.060 |
Why?
|
Stomach | 1 | 2007 | 270 | 0.060 |
Why?
|
Colectomy | 1 | 2025 | 73 | 0.060 |
Why?
|
PC12 Cells | 1 | 2004 | 25 | 0.060 |
Why?
|
CA-19-9 Antigen | 1 | 2024 | 10 | 0.060 |
Why?
|
Colorectal Surgery | 1 | 2004 | 9 | 0.060 |
Why?
|
Survival Analysis | 2 | 2022 | 1496 | 0.060 |
Why?
|
CA-125 Antigen | 1 | 2024 | 15 | 0.060 |
Why?
|
Carcinoembryonic Antigen | 1 | 2024 | 21 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2004 | 19 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 1294 | 0.050 |
Why?
|
Neurites | 1 | 2004 | 41 | 0.050 |
Why?
|
Cohort Studies | 2 | 2024 | 4819 | 0.050 |
Why?
|
Xenopus laevis | 1 | 2004 | 127 | 0.050 |
Why?
|
Chromatography, Affinity | 1 | 2003 | 70 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 1 | 2006 | 770 | 0.050 |
Why?
|
Protein Subunits | 1 | 2004 | 165 | 0.050 |
Why?
|
beta Catenin | 1 | 2025 | 215 | 0.050 |
Why?
|
Substrate Specificity | 1 | 2004 | 295 | 0.050 |
Why?
|
Age of Onset | 1 | 2025 | 600 | 0.050 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2004 | 343 | 0.050 |
Why?
|
DNA Primers | 1 | 2004 | 657 | 0.050 |
Why?
|
Paclitaxel | 1 | 2023 | 127 | 0.050 |
Why?
|
Plasmids | 1 | 2004 | 511 | 0.050 |
Why?
|
Mass Spectrometry | 1 | 2004 | 335 | 0.050 |
Why?
|
Needs Assessment | 1 | 2004 | 174 | 0.050 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 4415 | 0.050 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 86 | 0.050 |
Why?
|
DNA Mismatch Repair | 1 | 2022 | 53 | 0.050 |
Why?
|
Plant Proteins | 1 | 2002 | 76 | 0.050 |
Why?
|
Microfilament Proteins | 1 | 2004 | 278 | 0.050 |
Why?
|
Patients | 1 | 2023 | 119 | 0.050 |
Why?
|
Health Status Disparities | 1 | 2024 | 228 | 0.050 |
Why?
|
Melanoma, Experimental | 1 | 2021 | 35 | 0.050 |
Why?
|
Fatty Acids, Volatile | 1 | 2021 | 33 | 0.050 |
Why?
|
Blotting, Western | 1 | 2004 | 1109 | 0.050 |
Why?
|
Hepatocyte Growth Factor | 1 | 2021 | 30 | 0.050 |
Why?
|
eIF-2 Kinase | 1 | 2021 | 36 | 0.050 |
Why?
|
Cholangiography | 1 | 2021 | 14 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2024 | 858 | 0.050 |
Why?
|
Cell Membrane | 1 | 2003 | 461 | 0.050 |
Why?
|
Binding Sites | 1 | 2004 | 1303 | 0.040 |
Why?
|
Cytosol | 1 | 2021 | 162 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2015 | 1065 | 0.040 |
Why?
|
Tumor Suppressor Proteins | 1 | 2004 | 471 | 0.040 |
Why?
|
Fluorescence | 1 | 2021 | 96 | 0.040 |
Why?
|
Coloring Agents | 1 | 2021 | 77 | 0.040 |
Why?
|
Cholecystectomy | 1 | 2021 | 58 | 0.040 |
Why?
|
Indocyanine Green | 1 | 2021 | 56 | 0.040 |
Why?
|
Interleukin-1beta | 1 | 2021 | 163 | 0.040 |
Why?
|
Cell Cycle | 2 | 2015 | 610 | 0.040 |
Why?
|
Recombinant Proteins | 1 | 2004 | 1399 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2004 | 1701 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2024 | 439 | 0.040 |
Why?
|
Proteomics | 1 | 2003 | 506 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 299 | 0.040 |
Why?
|
Physician-Patient Relations | 1 | 2023 | 427 | 0.040 |
Why?
|
Morbidity | 2 | 2012 | 248 | 0.040 |
Why?
|
Mice, SCID | 1 | 2020 | 587 | 0.040 |
Why?
|
Communication | 1 | 2023 | 507 | 0.040 |
Why?
|
Mice, Knockout | 1 | 2006 | 3753 | 0.040 |
Why?
|
Virus Diseases | 1 | 2021 | 280 | 0.040 |
Why?
|
Molecular Sequence Data | 1 | 2004 | 3889 | 0.040 |
Why?
|
Tumor Cells, Cultured | 1 | 2020 | 1070 | 0.040 |
Why?
|
Breast Neoplasms | 1 | 2010 | 2516 | 0.040 |
Why?
|
Feces | 1 | 2021 | 727 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 2021 | 558 | 0.040 |
Why?
|
MAP Kinase Kinase 4 | 2 | 2011 | 37 | 0.040 |
Why?
|
Kidney | 1 | 2004 | 1353 | 0.030 |
Why?
|
Buffers | 1 | 2016 | 31 | 0.030 |
Why?
|
BRCA2 Protein | 1 | 2015 | 45 | 0.030 |
Why?
|
Genome, Human | 2 | 2013 | 1293 | 0.030 |
Why?
|
Retinoblastoma Protein | 1 | 2015 | 82 | 0.030 |
Why?
|
Genes, myc | 1 | 2015 | 105 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2022 | 857 | 0.030 |
Why?
|
Gene Amplification | 1 | 2015 | 235 | 0.030 |
Why?
|
Oxidative Phosphorylation | 1 | 2014 | 107 | 0.030 |
Why?
|
Risk Factors | 2 | 2025 | 10278 | 0.030 |
Why?
|
Cell Death | 1 | 2014 | 239 | 0.030 |
Why?
|
Indoles | 1 | 2015 | 191 | 0.030 |
Why?
|
Wnt Signaling Pathway | 1 | 2015 | 193 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2021 | 1716 | 0.030 |
Why?
|
Sulfonamides | 1 | 2015 | 270 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 1694 | 0.030 |
Why?
|
Systems Biology | 1 | 2013 | 58 | 0.030 |
Why?
|
North Carolina | 1 | 2012 | 59 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2004 | 3044 | 0.020 |
Why?
|
Models, Biological | 2 | 2010 | 1461 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2014 | 495 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2013 | 366 | 0.020 |
Why?
|
DNA Repair | 1 | 2015 | 589 | 0.020 |
Why?
|
Ohio | 1 | 2011 | 87 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2011 | 67 | 0.020 |
Why?
|
Genes, ras | 1 | 2011 | 100 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 577 | 0.020 |
Why?
|
Laparoscopes | 1 | 2010 | 3 | 0.020 |
Why?
|
Stochastic Processes | 1 | 2010 | 35 | 0.020 |
Why?
|
Urinary Diversion | 1 | 2010 | 43 | 0.020 |
Why?
|
Telomerase | 1 | 2011 | 169 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2011 | 345 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2011 | 214 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 368 | 0.020 |
Why?
|
Pelvis | 1 | 2010 | 68 | 0.020 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2010 | 71 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2015 | 963 | 0.020 |
Why?
|
Genes, p53 | 1 | 2010 | 216 | 0.020 |
Why?
|
United States | 1 | 2025 | 10884 | 0.020 |
Why?
|
Doxorubicin | 1 | 2010 | 288 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2015 | 1762 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2013 | 1275 | 0.020 |
Why?
|
Equipment Design | 1 | 2010 | 590 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 1095 | 0.020 |
Why?
|
Time Factors | 2 | 2011 | 6296 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2010 | 760 | 0.020 |
Why?
|
Shock, Traumatic | 1 | 2007 | 7 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 1033 | 0.020 |
Why?
|
Michigan | 1 | 2007 | 42 | 0.020 |
Why?
|
Trauma Severity Indices | 1 | 2007 | 79 | 0.020 |
Why?
|
Computational Biology | 1 | 2010 | 819 | 0.020 |
Why?
|
Urban Population | 1 | 2007 | 228 | 0.020 |
Why?
|
Sampling Studies | 1 | 2004 | 75 | 0.010 |
Why?
|
Streptavidin | 1 | 2003 | 4 | 0.010 |
Why?
|
Biotinylation | 1 | 2003 | 22 | 0.010 |
Why?
|
Algorithms | 1 | 2010 | 1630 | 0.010 |
Why?
|
Microspheres | 1 | 2003 | 70 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 1757 | 0.010 |
Why?
|
Probability | 1 | 2004 | 318 | 0.010 |
Why?
|
Laparotomy | 1 | 2004 | 135 | 0.010 |
Why?
|
Sorbitol | 1 | 2002 | 8 | 0.010 |
Why?
|
MAP Kinase Kinase 7 | 1 | 2002 | 11 | 0.010 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2002 | 45 | 0.010 |
Why?
|
RNA, Double-Stranded | 1 | 2002 | 63 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2002 | 92 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 107 | 0.010 |
Why?
|
Immunoblotting | 1 | 2002 | 308 | 0.010 |
Why?
|
Proteome | 1 | 2003 | 246 | 0.010 |
Why?
|
Ligands | 1 | 2002 | 538 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2002 | 297 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 3597 | 0.010 |
Why?
|
Length of Stay | 1 | 2004 | 1305 | 0.010 |
Why?
|
Drosophila | 1 | 2002 | 775 | 0.010 |
Why?
|
Incidence | 1 | 2004 | 3130 | 0.010 |
Why?
|
Risk Assessment | 1 | 2004 | 3422 | 0.010 |
Why?
|
Child, Preschool | 1 | 2007 | 14150 | 0.010 |
Why?
|
Adolescent | 1 | 2007 | 19412 | 0.000 |
Why?
|
Child | 1 | 2007 | 24609 | 0.000 |
Why?
|